GlassScriptPhysician profile
Joseph C Wan
NPI 1235549585
$3,632.70
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,173 · 2020: $507 · 2021: $574 · 2022: $114 · 2024: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,455.54 | 2019-2024 | Moses 550 Dfl, Ams 700 |
| Astellas Pharma US INC | $241.49 | 2019-2021 | |
| Medtronic USA, INC. | $194.82 | 2019-2020 | |
| Teleflex LLC | $136.61 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.01 | 2019 | |
| Janssen Scientific Affairs, LLC | $104.59 | 2019 | |
| Axonics, INC. | $58.54 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $47.25 | 2019-2021 | |
| Janssen Biotech, INC. | $43.30 | 2019 | |
| Abbvie INC. | $29.83 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $24.49 | 2019-2021 | |
| 180 Medical, INC. | $24.48 | 2021 | |
| Myriad Genetic Laboratories, INC. | $23.49 | 2021 | |
| Dendreon Pharmaceuticals LLC | $21.83 | 2020 | |
| Myovant Sciences INC. | $16.11 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $15.95 | 2020 | |
| Antares Pharma, INC. | $15.80 | 2020 | |
| Sun Pharmaceutical Industries INC. | $15.56 | 2020 | |
| Ferring Pharmaceuticals INC. | $15.17 | 2020 | |
| Pfizer INC. | $12.10 | 2020 | |
| Clarus Therapeutics INC. | $10.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Wan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.